Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

CUSIP: 877619106

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
285,714,286
Total 13F shares
13,698,356
Share change
-2,980,264
Total reported value
$9,051,371
Put/Call ratio
73%
Price per share
$0.66
Number of holders
37
Value change
-$2,014,707
Number of buys
11
Number of sells
17

Security key

877619106

Report period

Q2 2023

Institutions

37

Top holders

10

Top shareholders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
1.1%
3,087,338
$2,462,461 31 Mar 2023
13F
Nantahala Capital Management, LLC
13F
Company
0.6%
1,722,400
$1,350,706 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
0.55%
1,583,438
$1,262,950 31 Mar 2023
13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
0.52%
1,500,000
$1,196,400 31 Mar 2023
13F
Artal Group S.A.
13F
Company
0.5%
1,440,882
$1,149,000 31 Mar 2023
13F
Laurion Capital Management LP
13F
Company
0.45%
1,292,600
$1,030,978 31 Mar 2023
13F
FRANKLIN RESOURCES INC
13F
Company
0.28%
810,840
$646,726 31 Mar 2023
13F
Sands Capital Alternatives, LLC
13F
Company
0.25%
724,873
$579,898 31 Mar 2023
13F
Alphabet Inc.
13F
Company
0.22%
640,882
$512,706 31 Mar 2023
13F
Carlson Capital, L.P.
13F
Company
0.18%
504,000
$401,990 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.17%
477,045
$380,000 31 Mar 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.14%
405,301
$321,000 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
0.14%
397,485
$317,034 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
376,464
$300,267 31 Mar 2023
13F
Quantum Private Wealth, LLC
13F
Company
0.13%
359,367
$286,632 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.09%
249,600
$199,000 31 Mar 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
156,300
$124,665 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.05%
137,001
$109,190 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.04%
114,920
$91,660 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
100,044
$79,795 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.03%
87,813
$70,039 31 Mar 2023
13F
XTX Topco Ltd
13F
Company
0.03%
85,167
$67,929 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.03%
72,958
$58,191 31 Mar 2023
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.02%
55,359
$44,154 31 Mar 2023
13F
BANK OF MONTREAL /CAN/
13F
Company
0.02%
49,084
$40,249 31 Mar 2023
13F
Virtu Financial LLC
13F
Company
0.02%
45,459
$36,000 31 Mar 2023
13F
Redwood Wealth Management Group, LLC
13F
Company
0.01%
37,750
$30,109 31 Mar 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.01%
27,338
$22,000 31 Mar 2023
13F
Sargent Investment Group, LLC
13F
Company
0.01%
19,569
$15,068 31 Mar 2023
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.01%
18,725
$14,000 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.01%
16,140
$12,873 31 Mar 2023
13F
Kovitz Investment Group Partners, LLC
13F
Company
0.01%
15,000
$12,000 31 Mar 2023
13F
Engineers Gate Manager LP
13F
Company
0%
13,650
$10,887 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0%
11,293
$9,007 31 Mar 2023
13F
Camelot Portfolios, LLC
13F
Company
0%
11,000
$8,774 31 Mar 2023
13F
SIMPLEX TRADING, LLC
13F
Company
0%
10,767
$8,000 31 Mar 2023
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
10,000
$7,976 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
7,167
$6,000 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
4,045
$3,226 31 Mar 2023
13F
GROUP ONE TRADING LLC
13F
Company
0%
3,991
$3,183 31 Mar 2023
13F
UBS Group AG
13F
Company
0%
3,550
$2,833 31 Mar 2023
13F
JPMORGAN CHASE & CO
13F
Company
0%
1,782
$1,000 31 Mar 2023
13F
Allworth Financial LP
13F
Company
0%
1,000
$798 31 Mar 2023
13F
Audentes Therapeutics, Inc.
3/4/5
10%+ Owner
class O/S missing
7,266,342
$11,844,137 21 Oct 2022
Suyash Prasad
3/4/5
CMO and Head of R&D
class O/S missing
530,589
$864,860 05 Jul 2022
Kathleen Reape
3/4/5
Director
class O/S missing
36,200
22 Jun 2023

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q2 2023

As of 30 Jun 2023, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,698,356 shares. The largest 10 holders included VANGUARD GROUP INC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, Artal Group S.A., Nantahala Capital Management, LLC, Laurion Capital Management LP, FMR LLC, FRANKLIN RESOURCES INC, Sands Capital Ventures, LLC, Alphabet Inc., and MILLENNIUM MANAGEMENT LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
42
Q2 2023 holders
37
Holder diff
-5
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .